These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5723960)

  • 1. Effect of growth hormone on hepatic carcinogenesis and cirrhosis in AxC rats given N-2 fluorenyldiacetamide.
    Reuber MD
    Cancer Res; 1968 Nov; 28(11):2177-9. PubMed ID: 5723960
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of progesterone and diethylstilbestrol on hepatic carcinogenesis and cirrhosis in A X C rats fed N-2-fluorenyldiacetamide.
    REUBER MD; FIRMINGER HI
    J Natl Cancer Inst; 1962 Nov; 29():933-43. PubMed ID: 13981801
    [No Abstract]   [Full Text] [Related]  

  • 3. Systematic effect of testosterone on rat liver tumor induction by N-2-fluorenylacetamide.
    Toh YC
    J Natl Cancer Inst; 1972 Jan; 48(1):113-8. PubMed ID: 4652367
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of age and sex on carcinoma and cirrhosis of the liver in AXC strain rats ingesting 0.025% N-2-fluorenyldiacetamide.
    Reuber MD
    Pathol Microbiol (Basel); 1975; 43(1):31-7. PubMed ID: 179045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of age and testosterone on the induction of hyperplastic nodules, carcinomas, and cirrhosis of the liver in rats ingesting n-2-fluorenyldiacetamide.
    Reuber MD
    Eur J Cancer (1965); 1976 Feb; 12(2):137-41. PubMed ID: 1261571
    [No Abstract]   [Full Text] [Related]  

  • 6. Various degrees of susceptibility of different stocks of rats to N-2-fluorenyldiacetamide hepatic carcinogenesis.
    Reuber MD
    J Natl Cancer Inst; 1976 Jul; 57(1):111-4. PubMed ID: 187758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of adrenocorticotropic hormone and growth hormone on the metabolism of N-hydroxy-N-2-fluorenylacetamide and on physiologic parameters.
    Shirasu Y; Grantham PH; Weisburger EK; Weisburger JH
    Cancer Res; 1967 Jan; 27(1):81-7. PubMed ID: 4289799
    [No Abstract]   [Full Text] [Related]  

  • 8. Carcinoma and cirrhosis of the liver in A X C male rats with one kidney ingesting 0.025% N-2-fluorenyldiacetamide.
    Reuber MD
    Pathol Microbiol (Basel); 1975; 42(2):119-26. PubMed ID: 1178230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting effect of reserpine and female sensitivity in hepatic tumor induction with 2,7-diacetamidofluorene in SMA-Ms strain mice.
    Kozuka S
    Cancer Res; 1970 May; 30(5):1384-6. PubMed ID: 5426940
    [No Abstract]   [Full Text] [Related]  

  • 10. Importance of testes in induction of hyperplastic nodules, carcinomas, and cirrhosis of liver in A times C male rats ingesting 0.025 percent N-2-fluorenyldiacetamide.
    Reuber MD
    J Natl Cancer Inst; 1974 Sep; 53(3):883-6. PubMed ID: 4370092
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of alloxan diabetes on hepatic carcinogenesis and cirrhosis in A x C rats given 2-diacetamidofluorene.
    Reuber MD
    Gan; 1971 Jun; 62(3):157-61. PubMed ID: 5567075
    [No Abstract]   [Full Text] [Related]  

  • 12. The thyroid gland and N-2-fluorenyldiacetamide carcinogenesis and cirrhosis of the liver in Wistar male rats.
    Reuber MD
    J Natl Cancer Inst; 1965 Dec; 35(6):959-66. PubMed ID: 5892777
    [No Abstract]   [Full Text] [Related]  

  • 13. MORPHOLOGIC AND BIOLOGIC CORRELATION OF LESIONS OBTAINED IN HEPATIC CARCINOGENESIS IN A X C RATS GIVEN 0.025 PERCENT N-2-FLUORENYLDIACETAMIDE.
    REUBER MD; FIRMINGER HI
    J Natl Cancer Inst; 1963 Dec; 31():1407-29. PubMed ID: 14087658
    [No Abstract]   [Full Text] [Related]  

  • 14. Varying degrees of susceptibility of inbred strains of rats to N-2-fluorenyldiacetamide hepatic carcinogenesis.
    Reuber MD
    Toxicol Appl Pharmacol; 1976 Sep; 37(3):525-30. PubMed ID: 973225
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of preneoplastic and neoplastic lesions of the liver in male rats given 0.025 percent N-2-fluorenyldiacetamide.
    Reuber MD
    J Natl Cancer Inst; 1965 Jun; 34(6):697-723. PubMed ID: 4284030
    [No Abstract]   [Full Text] [Related]  

  • 16. Further studies on the transplantation of lesions in hepatic carcinogenesis in rats given 2-(diacetamido)fluorene.
    Reuber MD; Odashima S
    Gan; 1967 Dec; 58(6):513-20. PubMed ID: 5589523
    [No Abstract]   [Full Text] [Related]  

  • 17. N-hydroxy-2-acetylaminofluorene sulfotransferase: its probable role in carcinogenesis and in protein-(methion-S-yl) binding in rat liver.
    DeBaun JR; Miller EC; Miller JA
    Cancer Res; 1970 Mar; 30(3):577-95. PubMed ID: 5425283
    [No Abstract]   [Full Text] [Related]  

  • 18. The cellular analysis of liver carcinogenesis: ultrastructural alterations within hyperplastic liver nodules induced by 2-fluorenylacetamide.
    Merkow LP; Epstein SM; Caito BJ; Bartus B
    Cancer Res; 1967 Sep; 27(9):1712-21. PubMed ID: 6051282
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of 17 beta-estradiol and diethylstilbestrol on concurrent development of hepatic, mammary, and pituitary tumors in WF rats: evidence for differential effect on liver.
    Sumi C; Yokoro K; Matsushima R
    J Natl Cancer Inst; 1984 Nov; 73(5):1229-34. PubMed ID: 6593493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent effects of retinoids on pancreatic and liver carcinogenesis in azaserine-treated rats.
    Longnecker DS; Kuhlmann ET; Curphey TJ
    Cancer Res; 1983 Jul; 43(7):3219-25. PubMed ID: 6601985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.